Cefepime/piperacillin/tazobactamDevelopment of drug resistance and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1943卷 / 1期

关键词：

D O I：

10.1007/s40278-023-33077-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：192 / 192

相关论文

共 50 条

[41] Piperacillin/tazobactamDevelopment of resistance in Pseudomonas aeruginosa infection: case report
[J]. Reactions Weekly, 2018, 1706 (1) : 414 - 414
[42] Piperacillin/tazobactamDevelopment of resistance in Alcaligenes xylosoxidans endocarditis: case report
[J]. Reactions Weekly, 2013, 1478 (1) : 31 - 31
[43] RituximabCellulitis and off-label use: case report
[J]. Reactions Weekly, 2022, 1911 (1) : 363 - 363
[44] ClozapineSyncope and off-label use: case report
[J]. Reactions Weekly, 2022, 1930 (1) : 198 - 198
[45] Letermovir/valganciclovirLeukopenia, off-label use and drug resistance: 2 case reports
[J]. Reactions Weekly, 2023, 1984 (1) : 298 - 298
[46] AntineoplasticsReactive cutaneous capillary endothelial proliferation, emergence of drug resistance and off-label use: case report
[J]. Reactions Weekly, 2022, 1921 (1) : 41 - 41
[47] Piperacillin/tazobactamCandida lipolytica infection and off-label use
[J]. Reactions Weekly, 2024, 2008 (1) : 294 - 294
[48] Cefepime/piperacillin/tazobactamNeurotoxicity following drug overdose, and bacterial resistance: case report
[J]. Reactions Weekly, 2020, 1805 (1) : 77 - 77
[49] Mutiple drugsVarious toxicities, drug ineffective and off-label use: case report
[J]. Reactions Weekly, 2023, 1974 (1) : 272 - 272
[50] Multiple drugsLack of drug effect following off-label use: case report
[J]. Reactions Weekly, 2021, 1856 (1) : 289 - 289

← 1 2 3 4 5 →